![]() N-[3-(2-呋喃基)丙烯酰]-L-苯丙氨酰-甘氨酰-甘氨酸结构式
![]() |
常用名 | N-[3-(2-呋喃基)丙烯酰]-L-苯丙氨酰-甘氨酰-甘氨酸 | 英文名 | FA-Phe-Gly-Gly-OH |
---|---|---|---|---|
CAS号 | 64967-39-1 | 分子量 | 399.397 | |
密度 | 1.3±0.1 g/cm3 | 沸点 | 842.3±65.0 °C at 760 mmHg | |
分子式 | C20H21N3O6 | 熔点 | 245ºC (dec.)(lit.) | |
MSDS | 中文版 美版 | 闪点 | 463.2±34.3 °C |
用途N-[3-(2-呋喃)丙烯酰基]-Phe-Gly-Gly(FAPGG)是用于血管紧张素转换酶(ACE)测定的合成色甘酸底物[1]。 |
中文名 | N-[3-(2-呋喃基)丙烯酰]-L-苯丙氨酰-甘氨酰-甘氨酸 |
---|---|
英文名 | N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly |
中文别名 | N-(3-(2-呋喃基)丙烯氧基)-L-苯丙胺酰-G 甘氨酰-甘氨酸 | N-(3-(2-呋喃酰)丙烯酰-苯氨酰-谷氨酰-谷氨酸 |
英文别名 | 更多 |
描述 | N-[3-(2-呋喃)丙烯酰基]-Phe-Gly-Gly(FAPGG)是用于血管紧张素转换酶(ACE)测定的合成色甘酸底物[1]。 |
---|---|
相关类别 | |
参考文献 |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 842.3±65.0 °C at 760 mmHg |
熔点 | 245ºC (dec.)(lit.) |
分子式 | C20H21N3O6 |
分子量 | 399.397 |
闪点 | 463.2±34.3 °C |
精确质量 | 399.143036 |
PSA | 137.74000 |
LogP | 1.77 |
外观性状 | 灰白色至淡黄褐色的粉末 |
蒸汽压 | 0.0±3.3 mmHg at 25°C |
折射率 | 1.603 |
储存条件 | −20°C |
水溶解性 | NH4OH 1 M: 50 mg/mL, clear to slightly turbid, yellow |
个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
危害码 (欧洲) | Xi: Irritant; |
风险声明 (欧洲) | R36/37/38 |
安全声明 (欧洲) | 22-24/25 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
RTECS号 | OH2915000 |
海关编码 | 29321900 |
~73% N-[3-(2-呋喃基)丙烯酰... 64967-39-1 |
文献:Pozdnev, V. F. J. Gen. Chem. USSR (Engl. Transl.), 1986 , vol. 56, # 3 p. 690 - 695,613 - 617 |
~% N-[3-(2-呋喃基)丙烯酰... 64967-39-1 |
文献:J. Gen. Chem. USSR (Engl. Transl.), , vol. 56, # 3 p. 690 - 695,613 - 617 |
~% N-[3-(2-呋喃基)丙烯酰... 64967-39-1 |
文献:J. Gen. Chem. USSR (Engl. Transl.), , vol. 56, # 3 p. 690 - 695,613 - 617 |
~% N-[3-(2-呋喃基)丙烯酰... 64967-39-1 |
文献:J. Gen. Chem. USSR (Engl. Transl.), , vol. 56, # 3 p. 690 - 695,613 - 617 |
~% N-[3-(2-呋喃基)丙烯酰... 64967-39-1 |
文献:J. Gen. Chem. USSR (Engl. Transl.), , vol. 56, # 3 p. 690 - 695,613 - 617 |
Effect of power ultrasound pretreatment on peptidic profiles and angiotensin converting enzyme inhibition of milk protein concentrate hydrolysates.
J. Sci. Food Agric. 94(12) , 2420-8, (2014) The use of power ultrasound as a pretreatment to enhance the hydrolysis of milk protein concentrate (MPC) and subsequent angiotensin converting enzyme (ACE) inhibitory activity has been studied. Liqui... |
|
Assessment and optimization of kinetic methods for angiotensin-converting enzyme in plasma.
Clin. Chem. 39(2) , 312-6, (1993) In the kinetic angiotensin-converting enzyme (ACE) method, a practical and optimal buffer is 80 mmol/L borate buffer at pH 8.2 (37 degrees C). A lag phase is detected in the reaction, and a 5-min incu... |
|
Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme.
FEBS Lett. 550(1-3) , 84-8, (2003) The somatic isoform of angiotensin-converting enzyme (ACE) consists of two homologous domains (N- and C-domains), each bearing a catalytic site. We have used the two-domain ACE form and its individual... |
Glycine, N-[(2E)-3-(2-furanyl)-1-oxo-2-propen-1-yl]-L-phenylalanylglycyl- |
N-[(2E)-3-(2-Furyl)prop-2-enoyl]-L-phenylalanylglycylglycine |
N-[3-(2-Furyl)acryloyl]-L-phenylalanyl-glycyl-glycine |
N-[(2E)-3-(2-Furyl)-2-propenoyl]-L-phenylalanylglycylglycine |
FAPGG |